REGENERON PHARMACEUTICALS, INC. Convertible Notes Payable, Current
REGENERON PHARMACEUTICALS, INC. (REGN) had Convertible Notes Payable, Current of $300.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-11-04
- 2015-09-30: Convertible Notes Payable, Current $300.00K.
- 2015-06-30: Convertible Notes Payable, Current $2.00M.
- 2014-12-31: Convertible Notes Payable, Current $7.50M.
- 2014-09-30: Convertible Notes Payable, Current $0.00.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2015-09-30 | $300.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $2.00M 10-Q · filed 2015-08-04 |
| 2014-12-31 | $7.50M 10-Q · filed 2015-11-04 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-04 |
| 2013-12-31 | $0.00 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |